COLUMN GROUP III GP, LP's Net Worth
$211 Million
Who is COLUMN GROUP III GP, LP?
COLUMN GROUP III GP, LP has an estimated net worth of $211 Million. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Revolution Medicines, Inc., Tenaya Therapeutics, Inc., and Surrozen, Inc./DE.
SEC CIK
COLUMN GROUP III GP, LP's CIK is 0001790965
Past Insider Trading and Trends
2020 was COLUMN GROUP III GP, LP's most active year for acquiring shares with 43 total transactions. COLUMN GROUP III GP, LP's most active month to acquire stocks was the month of February. 2020 was COLUMN GROUP III GP, LP's most active year for disposing of shares, totalling 7 transactions. COLUMN GROUP III GP, LP's most active month to dispose stocks was the month of July. 2022 saw COLUMN GROUP III GP, LP paying a total of $24,999,998.40 for 9,615,384 shares, this is the most they've acquired in one year. In 2020 COLUMN GROUP III GP, LP cashed out on 10,058,647 shares for a total of $73,788,478.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.74M |
—
|
—
| 1K |
Apr 5
| |||
Form 4
| +3.64% | 64.09K |
$17.65 | $1,131,357.81 | 1.83M |
Sep 1 - Sep 2
| |||
Form 4
| +3.68% | 62.49K |
$17.83 | $1,114,381.76 | 1.76M |
Aug 27 - Aug 28
| |||
Form 4
| +1.10% | 18.45K |
$17.96 | $331,349.41 | 1.7M |
Aug 21 - Aug 25
| |||
Form 4
| +3.98% | 64.31K |
$17.65 | $1,135,362.37 | 1.68M |
Aug 13 - Aug 17
| |||
Form 4
| +0.05% | 732 |
$17.99 | $13,168.68 | 1.62M |
Jul 30
| |||
Form 4
| +0.25% | 4.11K |
$17.99 | $73,848.95 | 1.62M |
Jul 28
| |||
Form 4
| +4.71% | 72.58K |
$17.93 | $1,301,643.23 | 1.61M |
Jul 24 - Jul 27
| |||
Form 4
| +1.55% | 24.19K |
$15.68 | $323,874.00 | 1.58M |
May 15 - Jul 22
| |||
Form 4
| +7.89% | 112.6K |
$14.95 | $1,683,399.90 | 1.54M |
Apr 8
| |||
Form 4
| +10.73% | 138.31K |
$14.17 | $1,960,233.31 | 1.43M |
Apr 3 - Apr 7
| |||
Form 4
| +24.18% | 250.98K |
$12.40 | $3,111,020.93 | 1.29M |
Mar 31 - Apr 2
| |||
Form 4
| +40.87% | 301.18K |
$11.89 | $3,580,543.59 | 1.04M |
Mar 23 - Mar 25
| |||
Form 4
| +65.45% | 291.55K |
$11.68 | $3,404,772.90 | 736.99K |
Mar 19 - Mar 20
| |||
Form 4
| +1.90% | 8.31K |
$18.00 | $149,526.00 | 445.44K |
Mar 5
| |||
Form 4
| +16.80% | 62.87K |
$17.97 | $1,129,424.58 | 437.14K |
Mar 2 - Mar 4
| |||
Form 4
| +25.25% | 75.45K |
$17.91 | $1,351,593.36 | 374.27K |
Feb 26 - Feb 28
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +17.68% | 44.9K |
$15.96 | $716,604.00 | 298.82K |
Feb 6
| |||
Form 4
| +0.01% | 15 |
$12.00 | $180.00 | 253.92K |
Nov 11
| |||
Form 4
| +3.43% | 8.41K |
$11.99 | $100,823.91 | 253.91K |
Nov 4
| |||
Form 4
| +1.82% | 4.39K |
$11.93 | $52,351.82 | 245.5K |
Oct 22 - Oct 23
| |||
Form 4
| +54.39% | 84.94K |
$11.57 | $982,603.25 | 241.11K |
Oct 17 - Oct 21
| |||
Form 4
| +193.71% | 103K |
$10.31 | $1,061,930.00 | 156.17K |
Oct 14 - Oct 16
| |||
Form 4
|
∞
| 53.17K |
$10.44 | $555,292.92 | 53.17K |
Oct 9 - Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $29.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.68% | -2.03M |
$36.40 | -$73,788,478.40 | 4.58M |
Nov 16
| |||
Form 4
|
∞
| 7.23K |
—
|
—
| 7.23K |
Feb 12 - Jun 17
| |||
Form 4
|
∞
| 7.98M |
—
|
—
| 7.98M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.16% | -10.00K |
$36.95 | -$369,503.00 | 99.16K |
Feb 17
| |||
Form 4
| +1.18% | 30.11K |
$1.55 | $46,665.85 | 2.58M |
Dec 14
| |||
Form 4
| +0.69% | 41.67K |
$22.48 | $936,929.15 | 6.05M |
Mar 19 - Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $4.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.53% | 2.22M |
$4.50 | $9,999,999.00 | 13.6M |
Feb 12
| |||
Form 4
| +0.06% | 6.78K |
$2.60 | $17,595.57 | 11.38M |
Mar 10
| |||
Form 4
| +15.20% | 1.5M |
$2.60 | $3,900,000.00 | 11.37M |
Feb 8
| |||
Form 4
| +0.71% | 69.74K |
$2.50 | $174,201.05 | 9.87M |
Jan 19
| |||
Form 4
| +1.93% | 185.15K |
$2.51 | $464,827.06 | 9.8M |
Jan 17 - Jan 18
| |||
Form 4
|
∞
| 9.62M |
$2.60 | $24,999,998.40 | 9.62M |
Nov 21
| |||
Form 4
| +17,254.60% | 9.35M |
—
|
—
| 9.4M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surrozen, Inc./DE (SRZN) Snapshot price: $9.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +45.76% | 193.55K |
$15.50 | $2,999,994.00 | 616.54K |
Apr 4
| |||
Form 4
| +44.59% | 193.55K |
$15.50 | $2,999,994.00 | 627.65K |
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||